Adverse events34

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 34

Type	Event	Organ system	Group	Affected	At risk	Events
other	Lymphocyte count decreased	Investigations	Fostamatinib With Standard of Care for Treatment of COVID-19	4	30	4
other	Lymphocyte count decreased	Investigations	Placebo With Standard of Care for Treatment of COVID-19	7	29	7
other	Hypoalbuminemia	Metabolism and nutrition disorders	Fostamatinib With Standard of Care for Treatment of COVID-19	2	30	2
other	Hypoalbuminemia	Metabolism and nutrition disorders	Placebo With Standard of Care for Treatment of COVID-19	3	29	3
other	Hypokalemia	Metabolism and nutrition disorders	Fostamatinib With Standard of Care for Treatment of COVID-19	2	30	2
other	Hypokalemia	Metabolism and nutrition disorders	Placebo With Standard of Care for Treatment of COVID-19	1	29	1
other	Anemia	Blood and lymphatic system disorders	Fostamatinib With Standard of Care for Treatment of COVID-19	0	30	0
other	Anemia	Blood and lymphatic system disorders	Placebo With Standard of Care for Treatment of COVID-19	3	29	3
other	Hypocalcemia	Metabolism and nutrition disorders	Fostamatinib With Standard of Care for Treatment of COVID-19	0	30	0
other	Hypocalcemia	Metabolism and nutrition disorders	Placebo With Standard of Care for Treatment of COVID-19	2	29	2
other	Thromboembolic event	Vascular disorders	Fostamatinib With Standard of Care for Treatment of COVID-19	2	30	2
other	Thromboembolic event	Vascular disorders	Placebo With Standard of Care for Treatment of COVID-19	0	29	0
serious	Hypoglycemia	Endocrine disorders	Fostamatinib With Standard of Care for Treatment of COVID-19	1	30	1
serious	Hypoglycemia	Endocrine disorders	Placebo With Standard of Care for Treatment of COVID-19	0	29
serious	Bleeding	Gastrointestinal disorders	Fostamatinib With Standard of Care for Treatment of COVID-19	1	30	1
serious	Bleeding	Gastrointestinal disorders	Placebo With Standard of Care for Treatment of COVID-19	0	29
serious	Hypoxia	Respiratory, thoracic and mediastinal disorders	Fostamatinib With Standard of Care for Treatment of COVID-19	2	30	2
serious	Hypoxia	Respiratory, thoracic and mediastinal disorders	Placebo With Standard of Care for Treatment of COVID-19	3	29	3
serious	ACUTE RESPIRATORY FAILURE	Respiratory, thoracic and mediastinal disorders	Fostamatinib With Standard of Care for Treatment of COVID-19	1	30	1
serious	ACUTE RESPIRATORY FAILURE	Respiratory, thoracic and mediastinal disorders	Placebo With Standard of Care for Treatment of COVID-19	0	29

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04579393/events

API reference For AI assistants

Adverse events34

Sources 3

Read this list from software.